TOKYO (Reuters) – Japan’s Fujifilm Holdings Corp said on Friday it had stopped using its flu drug Avigan as a treatment for COVID-19.
The company had halted enrolling Avigan in a clinical trial in March.
(Reporting via Kantaro Komiya; Editing via Chang-Ran Kim)
This site is through reCAPTCHA and Google’s privacy policy and terms of use apply.